CD4+ Cancer Research Results
CD4+, CD4+ T Cells: Click to Expand ⟱
| Source: |
| Type: |
CD4+ T cells are T lymphocytes that express T cell receptors (TCRs).
Majority of cancer immunotherapies focus on harnessing the anti-tumour CD8+ cytotoxic T cell response, the potential role of CD4+ ‘helper’ T cells has largely remained in the background.
multifaceted role of CD4+ T cells in the anti-tumour immune response.
CD4+ T cells play a critical role in developing and sustaining effective anti-tumour immunity, even in cancer immunotherapies specifically designed to activate a CD8+ CTL response.
|
Scientific Papers found: Click to Expand⟱
*Dose↝, *Inflam↓, *AntiCan↑, *antiOx↑, *neuroP↑, *hepatoP↑, *cardioP↑, *P450↓, *SOD↑, *GPx↑, *Catalase↑, *ROS↓, *CD4+↑, *CD19↑, *NK cell↑, Casp3↑, Casp7↑, Casp8↑, Casp9↑, Fas↑, BAX↑, Bcl-2↓, *IL10↑, *TNF-α↓, *IL6↓, *iNOS↓, *COX2/PTGS2↓, *GSTs↑, *NF-kB↓, *AP-1↓, *cJun↓, *lipid-P↓, TumCG↓, DNAdam↑, TumCCA↑, MMP2↓, MMP9↓,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
Park, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
AntiCan↑, *neuroP↑, *cardioP↑, *AntiBio↑, *BioAv↑, *toxicity↓, *BioAv↑, *motorD↑, *SOD↑, *Catalase↑, *Keap1↑, *MDA↓, *GSH↑, *IL1β↓, *IL6↓, *TNF-α↓, *iNOS↓, *COX2/PTGS2↓, *lipid-P↓, *Cyt‑c↓, *ROS↓, *MMP↑, *antiOx↑, *AChE↓, *Apoptosis↓, *BAX↓, *Casp3↓, *Bcl-2↑, *BACE/β-secretase↓, *BChE↓, *eff↑, *Aβ↓, *ATP↑, RadioS↑, Cyt‑c↑, Casp3↑, Casp8↑, Casp9↑, Apoptosis↑, PARP↑, BAX↑, BID↑, NF-kB↑, Fas↑, EGFR↑, TIMP2↑, XIAP↓, COX2/PTGS2↓, Bak↓, Bcl-2↓, P53↑, HER2/EBBR2↓, FGF↓, CEA↓, Akt↓, TumCCA↑, *Imm↑, *CD4+↑, *CD8+↑, *BBB↑, *Pain↓, *cardioP↑, *TBARS↓, *SOD↑, *Catalase↑, *GSH↑, *AntiBio↑, *AntiFungal↑, *GastroP↑, *RenoP↑, *creat↓, *uricA↓, *Inflam↓, *iNOS↓, *COX2/PTGS2↓, *TNF-α↓, *IL6↑, *MMP13↓,
*Imm↑, *GastroP↑, *Inflam↓, AntiCan↑, *AntiBio↑, *hepatoP↑, *CD4+↑, *IFN-γ↓, *IL17↓, *GutMicro↑, *antiOx↑, *AST↓, *ALAT↓, *HDL↑, *LDL↓, *ROS↓, *lipid-P↓, *Inflam↓, *Aβ↓,
*Dose↝, *CD4+↑, *Th1 response↑, *NK cell↑, *Imm↑,
| - |
Review, |
Var, |
NA |
|
|
|
- |
Review, |
IBD, |
NA |
|
|
|
- |
Review, |
Stroke, |
NA |
|
|
|
- |
Review, |
Sepsis, |
NA |
|
|
|
- |
Review, |
AD, |
NA |
|
|
|
Dose↝, *Inflam↓, *IL1β↓, *IL6↓, *TNF-α↓, *neuroP↑, *mTOR↓, *IL10↑, *TGF-β↑, *Sepsis↓, *NRF2↑, *antiOx↑, *Catalase↑, *SOD↑, *GPx↑, *ROS↓, *HO-1↑, *PI3K↑, *Akt↑, *hepatoP↑, *MPO↓, *cardioP↑, CDK4↓, CDK6↑, CD47↓, PI3K↓, Akt↓, Hif1a↓, selectivity↑, *MMP↑, *ATP↑, *ER Stress↓, *CHOP/DDIT3↓, *Casp12↓, *GRP78/BiP↓, *p38↓, *p‑JNK↓, *LC3‑Ⅱ/LC3‑Ⅰ↑, *p‑eIF2α↓, *ATF4↓, *XBP-1↓, *Imm↑, *IFN-γ↓, *IL4↓, *GranB/GZMB↓, NK cell↑, radioP↑, *CD4+↑, CD8+↑, *Dose↝, *other↑, *Dose↝, *antiPs↑, *BioAv↝, *GutMicro↑, Dose↝, *IBI↑, TumCP↓, TumCI↓, TumCMig↓, CD8+↑, PGC-1α↑, Akt↓, SCD1↓, *MDA↓, Synergy↑, *APP↓, *BACE/β-secretase↓, *Aβ↓, *cognitive↑, *neuroP↑, NP/CIPN↓, *Stroke↓, *NLRP3↓, *ALAT↓, *AST↓, *LPS↓, *hepatoP↑, chemoP↑, *creat↓, *Urea↓, *RenoP↑, *eff↑, Apoptosis↑, XIAP↓, IAP2/BIRC3↓, TumVol↓, MALAT1↓, EZH2↓, miR-124-3p↓, eff↑, ChemoSen↑, *compII↑, *compIII↑, *LDL↓, *Obesity↓, QoL↑, PFS↑, *antiAll↑,
*antiOx↑, *Inflam↓, *Apoptosis↓, *Dose↓, *Dose↝, *eff↑, *ROS↓, *RNS↓, *NRF2↑, *HO-1↑, *Fenton↓, *NLRP3↓, *NADPH↓, *NOX4↓, *NOX↓, *MPO↓, *NF-kB↓, *TNF-α↓, *IL6↓, *IL1β↓, *HMGB1↓, *IL4↑, *IL10↑, *M2 MC↑, *Treg lymp↝, *Bcl-2↑, *Bcl-xL↑, *PI3K↑, *Akt↑, *JAK2↑, *STAT3↑, *Dose↑, *CD4+↑, *CD25+↑, *FOXP3↑, *MDA↓, *SOD↑, *Catalase↑, *Casp3↓, *Casp9↓, *TBARS↓, *SpO2↑, *VitE↓, *OS↑, *Weight↑, *DNAdam↓, *PGE2↓, *MCP1/CCL2↓, *lipid-P↓, *TumCP↓, *tumCV↓, *TumCMig↓, *TumCI↓, TumW↓, TumVol↓, selectivity↑, QoL↑, ChemoSen↑, chemoP↑, radioP↑, ROS↑, NLRP3↑, Casp3↑, VEGF↓, Wnt↓, β-catenin/ZEB1↓, *antiAll↑,
*AntiTum↑, *other↑, NA↝, *CD4+↑, *CD8+↑, TumCG↓, Imm↑,
*CD4+↑, *MCP1/CCL2↓, RANTES↓, *MIP‑1α/CCL3↓, *Treg lymp↓, *IFN-γ↓, *IL17↓, *CXCc↓,
Showing Research Papers: 1 to 8 of 8
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 8
Pathway results for Effect on Cancer / Diseased Cells:
NA, unassigned(tgid=0) ⓘ
NA↝, 1,
Redox & Oxidative Stress(tgid=1) ⓘ
ROS↑, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
PGC-1α↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
SCD1↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↑, 2, Bak↓, 1, BAX↑, 2, Bcl-2↓, 2, BID↑, 1, Casp3↑, 3, Casp7↑, 1, Casp8↑, 2, Casp9↑, 2, Cyt‑c↑, 1, Fas↑, 2, IAP2/BIRC3↓, 1, XIAP↓, 2,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↓, 3, EGFR↑, 1, HER2/EBBR2↓, 1, PI3K↓, 1,
Transcription & Epigenetics(tgid=7) ⓘ
EZH2↓, 1, miR-124-3p↓, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↑, 1, P53↑, 1, PARP↑, 1,
Cell Cycle & Senescence(tgid=11) ⓘ
CDK4↓, 1, CDK6↑, 1, TumCCA↑, 2,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
FGF↓, 1, TumCG↓, 2, TumCP↓, 1, Wnt↓, 1,
Migration(tgid=13) ⓘ
MALAT1↓, 1, MMP2↓, 1, MMP9↓, 1, TIMP2↑, 1, TumCI↓, 1, TumCMig↓, 1, β-catenin/ZEB1↓, 1,
Angiogenesis & Vasculature(tgid=14) ⓘ
Hif1a↓, 1, VEGF↓, 1,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD47↓, 1, CD8+↑, 2, COX2/PTGS2↓, 1, Imm↑, 1, NF-kB↑, 1, NK cell↑, 1, NLRP3↑, 1, RANTES↓, 1,
Drug Metabolism & Resistance(tgid=21) ⓘ
ChemoSen↑, 2, Dose↝, 2, eff↑, 1, RadioS↑, 1, selectivity↑, 2, Synergy↑, 1,
Clinical Biomarkers(tgid=22) ⓘ
CEA↓, 1, EGFR↑, 1, EZH2↓, 1, HER2/EBBR2↓, 1,
Functional Outcomes(tgid=23) ⓘ
AntiCan↑, 2, chemoP↑, 2, NP/CIPN↓, 1, PFS↑, 1, QoL↑, 2, radioP↑, 2, TumVol↓, 2, TumW↓, 1,
Total Targets: 68
Pathway results for Effect on Normal Cells:
Redox & Oxidative Stress(tgid=1) ⓘ
antiOx↑, 5, Catalase↑, 5, Fenton↓, 1, GPx↑, 2, GSH↑, 2, GSTs↑, 1, HDL↑, 1, HO-1↑, 2, Keap1↑, 1, lipid-P↓, 4, MDA↓, 3, MPO↓, 2, NOX↓, 1, NOX4↓, 1, NRF2↑, 2, RNS↓, 1, ROS↓, 5, SOD↑, 5, TBARS↓, 2, uricA↓, 1, VitE↓, 1,
Mitochondria & Bioenergetics(tgid=3) ⓘ
compII↑, 1, compIII↑, 1,
Core Metabolism/Glycolysis(tgid=4) ⓘ
ALAT↓, 2, ATP↑, 2, LDL↓, 2, NADPH↓, 1,
Cell Death(tgid=5) ⓘ
Apoptosis↓, 2, BAX↓, 1, Bcl-2↑, 2, Bcl-xL↑, 1, Casp12↓, 1, Casp3↓, 2, Casp9↓, 1, Cyt‑c↓, 1, GranB/GZMB↓, 1, iNOS↓, 3, p38↓, 1,
Kinase & Signal Transduction(tgid=6) ⓘ
Akt↑, 2, JAK2↑, 1, p‑JNK↓, 1, mTOR↓, 1, PI3K↑, 2, STAT3↑, 1,
Transcription & Epigenetics(tgid=7) ⓘ
ATF4↓, 1, cJun↓, 1, other↑, 2, tumCV↓, 1,
Protein Folding & ER Stress(tgid=8) ⓘ
CHOP/DDIT3↓, 1, p‑eIF2α↓, 1, ER Stress↓, 1, GRP78/BiP↓, 1, XBP-1↓, 1,
Autophagy & Lysosomes(tgid=9) ⓘ
LC3‑Ⅱ/LC3‑Ⅰ↑, 1,
DNA Damage & Repair(tgid=10) ⓘ
DNAdam↓, 1,
Proliferation, Differentiation & Cell State(tgid=12) ⓘ
TumCP↓, 1,
Migration(tgid=13) ⓘ
AP-1↓, 1, MMP13↓, 1, TGF-β↑, 1, TumCI↓, 1, TumCMig↓, 1,
Barriers & Transport(tgid=15) ⓘ
BBB↑, 1, GastroP↑, 2, IBI↑, 1, MMP↑, 2,
Immune & Inflammatory Signaling(tgid=16) ⓘ
CD19↑, 1, CD25+↑, 1, CD4+↑, 8, CD8+↑, 2, COX2/PTGS2↓, 3, CXCc↓, 1, FOXP3↑, 1, HMGB1↓, 1, IFN-γ↓, 3, IL10↑, 3, IL17↓, 2, IL1β↓, 3, IL4↓, 1, IL4↑, 1, IL6↓, 4, IL6↑, 1, Imm↑, 4, Inflam↓, 6, LPS↓, 1, M2 MC↑, 1, MCP1/CCL2↓, 2, MIP‑1α/CCL3↓, 1, NF-kB↓, 2, NK cell↑, 2, NLRP3↓, 2, PGE2↓, 1, Th1 response↑, 1, TNF-α↓, 5, Treg lymp↓, 1, Treg lymp↝, 1,
Synaptic & Neurotransmission(tgid=18) ⓘ
AChE↓, 1, BChE↓, 1,
Protein Aggregation(tgid=19) ⓘ
APP↓, 1, Aβ↓, 3, BACE/β-secretase↓, 2,
Drug Metabolism & Resistance(tgid=21) ⓘ
BioAv↑, 2, BioAv↝, 1, Dose↓, 1, Dose↑, 1, Dose↝, 5, eff↑, 3, P450↓, 1,
Clinical Biomarkers(tgid=22) ⓘ
ALAT↓, 2, AST↓, 2, creat↓, 2, IL6↓, 4, IL6↑, 1, SpO2↑, 1, Urea↓, 1,
Functional Outcomes(tgid=23) ⓘ
antiAll↑, 2, AntiCan↑, 1, antiPs↑, 1, AntiTum↑, 1, cardioP↑, 4, cognitive↑, 1, hepatoP↑, 4, motorD↑, 1, neuroP↑, 4, Obesity↓, 1, OS↑, 1, Pain↓, 1, RenoP↑, 2, Stroke↓, 1, toxicity↓, 1, Weight↑, 1,
Infection & Microbiome(tgid=24) ⓘ
AntiBio↑, 3, AntiFungal↑, 1, GutMicro↑, 2, Sepsis↓, 1,
Total Targets: 134
Scientific Paper Hit Count for: CD4+, CD4+ T Cells
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:% Cells:1 prod#:% Target#:544 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page